The issue of plasma asymmetric dimethylarginine reference range - A systematic review and meta-analysis

PLoS ONE

Volumn 12, Issue 5, 2017, Pages

  Németh, Balázs ^a   Ajtay, Zénó ^a   Hejjel, László ^a   Ferenci, Tamás ^b   Ábrám, Zoltán ^c   Murányi, Edit ^a   Kiss, István ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b OBUDA UNIVERSITY   (Hungary)

^c UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

N(G),N(G) DIMETHYLARGININE; ARGININE; N,N-DIMETHYLARGININE;

AGE; AMINO ACID BLOOD LEVEL; ARTICLE; BODY MASS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ANALYSIS; GENDER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; QUANTITATIVE ANALYSIS; REFERENCE VALUE; SYSTEMATIC REVIEW; ANALOGS AND DERIVATIVES; BLOOD; CONFIDENCE INTERVAL; FEMALE; MALE; META ANALYSIS;

ARGININE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CONFIDENCE INTERVALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; REFERENCE VALUES;

EID: 85018860682     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0177493     Document Type: Article

References (34)

1. Cooke JP. Asymmetrical dimethylarginine: the Über marker? Circulation. 2004; 109(15): 1813-1818. https://doi.org/10.1161/01.CIR.0000126823.07732.D5 PMID: 15096461
2. Jin RC, Loscalzo J. Vascular nitric oxide: formation and function. J Blood Med. 2010; 1: 147-162.
3. Blackwell S, O'Reilly DS, Talwar D. Biological variation of asymmetric dimethylarginine and related arginine metabolites and analytical performance goals for their measurement in human plasma. Eur J Clin Invest. 2007; 37(5): 364-371. https://doi.org/10.1111/j.1365-2362.2007.01798.x PMID: 17461982
4. Lu TM, Ding YA, Lin SJ, Lee WS, Tai HC. Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention. Eur Heart J. 2003; 24(21): 1912-1919. PMID: 14585249
5. Sydow K, Münzel T. ADMA and oxidative stress. Atheroscler Suppl. 2003; 4(4): 41-51. PMID: 14664902
6. Sydow K, Fortmann SP, Fair JM, Varady A, Hlatky MA, Go AS, et al. Distribution of asymmetric dimethylarginine among 980 healthy, older adults of different ethnicities. Clin Chem. 2010; 56(1): 111-120. https://doi.org/10.1373/clinchem.2009.136200 PMID: 19892843
7. Sibal L, Agarwal SC, Home PD, Boger RH. The role of asymmetric dimethylarginine (ADMA) in endothelial dysfunction and cardiovascular disease. Curr Cardiol Rev. 2010; 6(2): 82-90. https://doi.org/10.2174/157340310791162659 PMID: 21532773
8. Vassiliadis E, Barascuk N, Didangelos A, Karsdal MA. Novel cardiac-specific biomarkers and the cardiovascular continuum. Biomark Insights. 2012; 7: 45-57. https://doi.org/10.4137/BMI.S9536 PMID: 22577298
9. Owczarek D, Cibor D, Mach T. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), arginine, and 8-iso-prostaglandin F2alpha (8-iso-PGF2alpha) level in patients with inflammatory bowel diseases. Inflamm Bowel Dis. 2010; 16(1): 52-57. https://doi.org/10.1002/ibd.20994 PMID: 19575355
10. Riccioni G, Scotti L, D'Orazio N, Gallina S, Speziale G, Speranza L, et al. ADMA/SDMA in elderly subjects with asymptomatic carotid atherosclerosis: values and site-specific association. Int J Mol Sci. 2014; 15(4): 6391-6398. https://doi.org/10.3390/ijms15046391 PMID: 24739810
11. Furuki K, Adachi H, Enomoto M. Plasma level of asymmetric dimethylarginine (ADMA) as a predictor of carotid intima-mediathickness progression: Six-year prospective study using carotid ultrasonography. Hypertens Res. 2008; 31(6): 1185-1189. https://doi.org/10.1291/hypres.31.1185 PMID: 18716367
12. Schnabel R, Blankenberg S, Lubos E, Lackner KJ, Rupprecht HJ, Espinola-Klein C, et al. Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study. Circ Res. 2005; 97(5): e53-e59. https://doi.org/10.1161/01. RES.0000181286.44222.61 PMID: 16100045
13. Schulze F, Lenzen H, Hanefeld C, Bartling A, Osterziel KJ, Goudeva L, et al. Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study. Am Heart J. 2006; 152(3): 493.e1-493e8.
14. Korkmaz GG, Altinoglu E, Civelek S, Sozer V, Erdenen F, Tabak O, et al.: The association of oxidative stress markers with conventional risk factors in the metabolic syndrome. Metabolism. 2013; 62(6): 828-835. https://doi.org/10.1016/j.metabol.2013.01.002 PMID: 23410746
15. Leong T, Zylberstein D, Graham I, Lissner L, Ward D, Fograty J, et al. Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg. Arterioscler Thromb Vasc Biol. 2008; 28(5): 961-967. https://doi.org/10.1161/ATVBAHA.107.156596 PMID: 18292394
16. Böger RH, Sullivan LM, Schwedhelm E, Wang TJ, Maas R, Benjamin EJ, et al. Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community. Circulation. 2009; 119(12): 1592-1600. https://doi.org/10.1161/CIRCULATIONAHA.108.838268 PMID: 19289633
17. Willeit P, Freitag DF, Laukkanen JA, Chowdhury S, Gobin R, Mayr M, et al. Asymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studies. J Am Heart Assoc. 2015; 4(6): e001833. https://doi.org/10.1161/JAHA.115.001833 PMID: 26021436
18. Schulze F, Wesemann R, Schwedhelm E, Sydow K, Albsmeier J, Cooke JP, et al. Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay. Clin Chem Lab Med. 2004; 42(12): 1377-1383. https://doi.org/10.1515/CCLM.2004.257 PMID: 15576299
19. Siroká R, Trefil L, Rajdl D, Racek J, Cibulka R. Asymmetric dimethylarginine-comparison of HPLC and ELISA methods. J Chromatogr B Analyt Technol Biomed Life Sci. 2007; 850(1-2): 586-587. https://doi.org/10.1016/j.jchromb.2006.12.009 PMID: 17197253
20. Hov GG, Sagen E, Bigonah A, Asberg A. Health-associated reference values for arginine, asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) measured with high-performance liquid chromatography. Scand J Clin Lab Invest. 2007; 67(8): 868-876. https://doi.org/10.1080/00365510701429836 PMID: 17852822
21. Schwedhelm E, Xanthakis V, Maas R, Sullivan LM, Schulze F, Riederer U, et al. Asymmetric dimethylarginine reference intervals determined with liquid chromatography-tandem mass spectrometry: results from the Framingham offspring cohort. Clin Chem. 2009; 55(8): 1539-1545. https://doi.org/10.1373/clinchem.2009.124263 PMID: 19541865
22. Deneva-Koycheva TI, Vladimirova-Kitova LG, Angelova EA, Tsvetkova TZ. Plasma asymmetric dimethylarginine levels in healthy people. Folia Med (Plovdiv). 2011; 53(1): 28-33.
23. Schulze F, Maas R, Freese R, Schwedhelm E, Silberhorn E, Boger RH. Determination of a reference value for N(G), N(G)-dimethyl-L-arginine in 500 subjects. Eur J Clin Invest. 2005; 35(10): 622-626. https://doi.org/10.1111/j.1365-2362.2005.01561.x PMID: 16178881
24. Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014; 14: 135. https://doi.org/10.1186/1471-2288-14-135 PMID: 25524443
25. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999; 8(2): 135-160. https://doi.org/10.1177/096228029900800204 PMID: 10501650
26. Borenstein M, Hedges LV, Higgins J, Rothstein HR. Introduction to Meta-Analysis. Chichester: John Wiley & Sons, Ltd; 2009.
27. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2016. https://www.R-project.org/
28. Viechtbauer W. Conducting meta-analyses in R with the metafor package. Journal of Statistical Software. 2010; 36(3): 1-48. Available from: http://www.jstatsoft.org/v36/i03/
29. Kaushik N, Green S. Pre-analytical errors: their impact and how to minimize them. MLO Med Lab Obs. 2014; 46(5): 22, 24, 26. Available from: http://www.mlo-online.com/pre-analytical-errors-their-impactand-how-to-minimize-them.php. PMID: 24902378
30. Sakyi AS, Laing EF, Ephraim RK, Asibey OF, Sadique OK. Evaluation of analytical errors in a clinical chemistry laboratory: A 3 year experience. Annals of Medical and Health Sciences Research. 2015; 5(1): 8-12. https://doi.org/10.4103/2141-9248.149763 PMID: 25745569
31. Zincir S, Zincir SB, Doruk A, Erdem M, Celik C, Ak M, et al. Asymmetric dimethylarginine (ADMA) and treatment response relationship in male patients with first-episode schizophrenia: a controlled study. Psychiatry Res. 2014; 220(1-2): 76-80. https://doi.org/10.1016/j.psychres.2014.07.013 PMID: 25095755
32. Turkcuoglu I, Engin-Ustun Y, Turan F, Kali Z, Karabulut AB, Meydanli M, et al. Evaluation of asymmetric dimethylarginine, nitric oxide levels and associated independent variables in obese and lean patients with polycystic ovarian syndrome. Gynecol Endocrinol. 2011; 27(9): 609-614. https://doi.org/10.3109/09513590.2010.507291 PMID: 20695761
33. Martens-Lobenhoffer J, Westphal S, Awiszus F, Bode-Böger SM, Luley C. Determination of asymmetric dimethylarginine: liquid chromatography-mass spectrometry or ELISA? Clin Chem. 2005; 51(11): 2188-2189. https://doi.org/10.1373/clinchem.2005.056788 PMID: 16244300
34. Horowitz JD, Heresztyn T. An overview of plasma concentrations of asymmetric dimethylarginine (ADMA) in health and disease and in clinical studies: methodological considerations. J Chromatogr B. 2007; 851(1-2): 42-50.